Order of the Supreme Court of India in the matter of Network of People Living With HIV/AIDS & Others Vs Union of India & Others dated 24/02/2025. The Supreme Court (SC), February 24, 2025 has directed all states to file their affidavits addressing concerns raised about antiretroviral therapy (ART) drugs …
The health ministry has suggested that the pricing of essential medicines be based on either the average price of the three cheapest brands or the government’s bulk procurement price, rejecting a draft policy of the department of pharmaceuticals. The ministry’s recommendation, made earlier this month, has drawn flak from drug …
Instead of giving medicines free only to its own certified poor, the government should subsidise essential drugs for everyone-----------The public distribution system and the employment guarantee scheme are the government’s flagship programmes to reduce poverty. They are also its most effective programmes to create wealth among those in or close …
Admitting that the healthcare system was “overwhelmed” by inequities, Health Minister Ghulam Nabi Azad on Monday said the government would provide universal healthcare in the 12th Plan and take steps to ensure free generic drugs at all public health facilities so as to reduce out of pocket expenditure of patients. …
DHAR KHURD (PATHANKOT): The vulture conservation project which was launched some three years back may not meet the desired goals due to half-hearted approach adopted by the government. Not only two out of three "vulture restaurants" set up by state government have been abandoned, the wildlife department also doesn't have …
Panacea Biotec has launched polio vaccine POLPROTEC in Nigeria to help combat the spread of the debilitating disease in the country, one of the last nations still to eradicate the virus. To make the vaccine easily available, Panacea is partnering Emzor Pharma, which has a strong footprint across Nigeria. During …
The Open Source Drug Discovery network's army of volunteers is building a kind of Wikipedia on tuberculosis, which is the leading cause of death in India for those in the prime of life.
Market cheers to news as shares of India’s 3rd largest drug maker rise 4%. Shares of Sun Pharma, India’s third largest drug maker, rose 4% on Wednesday after the US drug regulator said it will import generic version of the cancer drug Lipidox from Sun Pharma to meet a supply …
The second day of the ongoing 30th National Workshop on Clinical Pharmacology, in the department of Pharmacology, PGIMER, Chandigarh, began with the lecture of Prof P L Sharma. He spoke on various issues in multicentre clinical trials. Multicentre clinical trials are conducted according to one common study protocol at several …
New Delhi/Mumbai: Despite talk of a slowing economy, improved sentiments of late have warmed India Inc to the prospects of a year of doubledigit salary hikes, an average of 11.9% compared to last year’s 12.6%, says a survey by human-resource consulting firm Aon Hewitt. Despite the moderation in hikes, increments …
Kerala, a role-model for the rest of the nation on many aspects of social development, has added one more feather to its cap. It’s set a record in reaching anti-rabies vaccine to the maximum number of people. As per the statistics received from Thiruvananthapuram Medical College (TMC), the state has …
New Delhi: Free medicines to all patients visiting any government health facility across the country could soon be a reality with the health ministry ready to roll out a nearly Rs 30,000-crore ‘free medicines for all’ scheme with strong backing from the Prime Minister’s Office (PMO). The free medicine initiative, …
Pulled up by the Supreme Court, the ministry of chemicals and fertilisers has set a deadline of three weeks for a final version of its draft pharma policy before the group of ministers (GoM) constituted for the purpose two years earlier. The ministry on Thursday assured the Supreme Court of …
On the eve of a high-level summit between the leaders of India and the European Union (EU) in Delhi, Oxfam has called upon the EU to not pressurise India into agreeing to new trade rules that could deny hundreds of millions of people access to affordable medicines. Calling on the …
While biotech and pharma are referred to as sunrise sectors, a new study reveals only an insignificant amount of innovative, patentable work has been carried out so far as part of the outsourcing process to Indian pharma-biotech firms. The study titled “work outsourced to Indian biotech and pharma companies is …
Mediator, a drug licensed for use by diabetics that became widely prescribed in France as a slimming aid, "probably" caused at least 1,300 deaths before it was withdrawn, a study published on Thursday said. Mahmoud Zureik of the National Institute of Health and Medical Research (Inserm), who co-led the probe, …
A Central team from the National AIDS Control Organisation, New Delhi, which is in the State to evaluate the care, support and treatment programmes implemented by Tamil Nadu, has said that there are lessons here for the rest of the country to follow. For instance, there is high praise for …
NGO says there has been a rampant compromise with human life The Supreme Court on Monday issued notice to the Centre on a writ petition alleging that illegal clinical trials of untested drugs were being conducted by pharmaceutical companies on adults, children and even mentally ill persons in various States. …
The Supreme Court on Monday issued notices to the Ministry of Health and Family Welfare and the Medical Council of India on a petition seeking judicial intervention into allegations of clinical trials of untested drugs being conducted on patients, mostly poor, without taking their prior “informed” consent. A PIL taken …
The Supreme Court today sought the Centre's response on conducting an independent inquiry into alleged illegal clinical trials of untested drugs by pharmaceutical companies in various states. The court issued a notice to the Centre as also to the Health Ministry and the Medical Council of India seeking their replies …
The Supreme Court today sought the Centre’s response on a PIL seeking inquiry into alleged illegal clinical trials of untested drugs in various States of the country. A Bench of Justices, Mr R.M. Lodha and Mr H.L. Gokhale, issued notice to the Centre, the Health Ministry and Medical Council of …
